Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yutaka Horiguchi

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Journal of Cellular and Molecular Medicine|November 30, 2021
Efficacy of a cultured conditioned medium of exfoliated deciduous dental pulp stem cells in erectile dysfunction patientsShoji Koga, Yutaka Horiguchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 26, 2003
[Prostate specific membrane antigen (PSMA) as a role of tumor marker]Shiro Saito, Yutaka Horiguchi, Masaru Murai
Expert Review of Anticancer Therapy|December 23, 2003
Antitumor effect of a novel nuclear factor-kappa B activation inhibitor in bladder cancer cellsYutaka Horiguchi, Kenji Kuroda, Jun Nakashima, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Angiotensin II type 1 receptor antagonist candesartan as an angiogenic inhibitor in a xenograft model of bladder cancerMichio Kosugi, Akira Miyajima, Eiji Kikuchi, et al.
Life Sciences|July 23, 2008
Effects of a KiSS-1 peptide, a metastasis suppressor gene, on the invasive ability of renal cell carcinoma cells through a modulation of a matrix metalloproteinase 2 expressionKunihiko Yoshioka, Yoshio Ohno, Yutaka Horiguchi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 3, 2008
Prediction of bone metastases by combination of tartrate-resistant acid phosphatase, alkaline phosphatase and prostate specific antigen in patients with prostate cancerChoichiro Ozu, Jun Nakashima, Yutaka Horiguchi, et al.
Human Cell|May 18, 2007
Effect of angiotensin II type 1 receptor antagonist on tumor growth and angiogenesis in a xenograft model of human bladder cancerMichio Kosugi, Akira Miyajima, Eiji Kikuchi, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 3, 2012
[NF-kappaB inhibitor]Jun Nakashima, Yutaka Horiguchi, Yoshio Ohno, et al.
The Journal of Urology|January 25, 2003
Enhancement of diethylstilbestrol induced cytotoxicity by bcl-2 antisense oligodeoxynucleotides and a glutathione depletor for prostate cancerEiji Kikuchi, Jun Nakashima, Yutaka Horiguchi, et al.
Urology|January 27, 2009
Angiotensin II type 1 receptor antagonist enhances cis-dichlorodiammineplatinum-induced cytotoxicity in mouse xenograft model of bladder cancerMichio Kosugi, Akira Miyajima, Eiji Kikuchi, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Journal of Cellular and Molecular Medicine|November 30, 2021
Efficacy of a cultured conditioned medium of exfoliated deciduous dental pulp stem cells in erectile dysfunction patientsShoji Koga, Yutaka Horiguchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 26, 2003
[Prostate specific membrane antigen (PSMA) as a role of tumor marker]Shiro Saito, Yutaka Horiguchi, Masaru Murai
Expert Review of Anticancer Therapy|December 23, 2003
Antitumor effect of a novel nuclear factor-kappa B activation inhibitor in bladder cancer cellsYutaka Horiguchi, Kenji Kuroda, Jun Nakashima, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Angiotensin II type 1 receptor antagonist candesartan as an angiogenic inhibitor in a xenograft model of bladder cancerMichio Kosugi, Akira Miyajima, Eiji Kikuchi, et al.
Life Sciences|July 23, 2008
Effects of a KiSS-1 peptide, a metastasis suppressor gene, on the invasive ability of renal cell carcinoma cells through a modulation of a matrix metalloproteinase 2 expressionKunihiko Yoshioka, Yoshio Ohno, Yutaka Horiguchi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 3, 2008
Prediction of bone metastases by combination of tartrate-resistant acid phosphatase, alkaline phosphatase and prostate specific antigen in patients with prostate cancerChoichiro Ozu, Jun Nakashima, Yutaka Horiguchi, et al.
Human Cell|May 18, 2007
Effect of angiotensin II type 1 receptor antagonist on tumor growth and angiogenesis in a xenograft model of human bladder cancerMichio Kosugi, Akira Miyajima, Eiji Kikuchi, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 3, 2012
[NF-kappaB inhibitor]Jun Nakashima, Yutaka Horiguchi, Yoshio Ohno, et al.
The Journal of Urology|January 25, 2003
Enhancement of diethylstilbestrol induced cytotoxicity by bcl-2 antisense oligodeoxynucleotides and a glutathione depletor for prostate cancerEiji Kikuchi, Jun Nakashima, Yutaka Horiguchi, et al.
Urology|January 27, 2009
Angiotensin II type 1 receptor antagonist enhances cis-dichlorodiammineplatinum-induced cytotoxicity in mouse xenograft model of bladder cancerMichio Kosugi, Akira Miyajima, Eiji Kikuchi, et al.
Pageof 6